TrialPath

Find a study

Match me to a study

227 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

ListMap
Weight & metabolicMental healthLungs & breathingHeart & circulationKidneyBrain & memoryBlood disordersImmune & autoimmuneSkin

148 studies on the map

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis — Southern Arizona VA Health Care System, Tucson, AZ, TucsonA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Banner Sun Health Research Institute, Sun CityA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease — University of Alabama at Birmingham, BirminghamA Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease — Banner Sun Health Research Institute, Sun CityParkinson's Foundation PD GENEration Genetic Registry — University of Alabama Birmingham, BirminghamA Study of Buntanetap in Participants With PD — University of Alabama at Birmingham, BirminghamA Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) — Mayo Clinic, PhoenixPPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — University of Alabama at Birmingham, BirminghamStudy in Parkinson Disease of Exercise — University of Alabama at Birmingham, BirminghamA US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications — Banner Alzheimer's Institute (BAI)-Phoenix, PhoenixA Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations — University of Arkansas for Medical Sciences, Little RockAbbott DBS Post-Market Study of Outcomes for Indications Over Time — University of Aizona Health Sciences, TucsonRegistry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Neurology and Pain Specialty, Aliso ViejoA Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease — Barrow Neurological Institute, PhoenixA Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease — Site-049, BirminghamBlack and African Americans Connections to Parkinson's Disease (BLAAC PD) — University of Alabama at Birmingham, BirminghamDeep Brain Stimulation (DBS) Retrospective Outcomes Study — St. Joseph's Hospital & Medical Center, PhoenixUse of CereGate Therapy for Freezing of Gait in PD — Kaiser Permanente, KPNC Comprehensive Movement Disorders Program, Redwood CityA Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease — Miami Neuroscience Institute Baptist Health, MiamiA Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease — Collaborative Neuroscience Network - CNS, Los AlamitosNatural History Study of Synucleinopathies — NYU Medical Center, New YorkA Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications — University of Maryland, Baltimore, BaltimoreThe Parkinson's Genetic Research Study — Emory University/ Wesley Woods Health Center, AtlantaSAD Study in Patients With Parkinson's Disease and Motor Fluctuations — Rocky Mountain Clinical Research, EnglewoodReal-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: — Parkinson's Disease and Movement Disorders Center - Orange County (South), Aliso ViejoA Pilot Study of In-lab Dynamic Standing in Parkinson's Disease — Domino's Farms, Ann ArborThis Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease. — Cornell University Weill Medical College, New YorkImaging Core Aim 2, and Udall Project 2 Aim 2 — University of Minnesota, MinneapolisEarly Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging) — Institute for Neurodegenerative Disorders, New HavenSafety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers — UCSF, San FranciscoThe GBA Multimodal Study in Parkinson's Disease — Oregon Health & Science University, PortlandTURN-IT FOG: Improving Turning and Freezing of Gait in People With PD — Arizona State University, TempeClinical Outcomes for Deep Brain Stimulation — Washington University in St Louis, St LouisAdaptive DBS to Offset STN Dysregulation During Exercise in PD — University of Colorado, AuroraEffects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease — The Regenesis Project, Santa MonicaAdaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2) — University of Nebraska Medical Center, OmahaVirtual Cycling Environments for Persons With Parkinson Disease — School of Health Professions, NewarkA Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease — University of Kentucky Medical Center, LexingtonRehabilitation of Airway Protection in Parkinson's Disease — Purdue University, West LafayetteA Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease — Austin Clinic PPD, AustinEfficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners — Raw Kickboxing and Fitness, Coral SpringsIntranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease — Institute for Neuroimmune Medicine, DavieComparing Antipsychotic Medications in LBD Over Time — University Health System, San AntoniorTMS to Improve Cognition in Parkinson's — Jesse Brown VA Medical Center, Chicago, IL, ChicagoCortical Electrophysiology of Response Inhibition in Parkinson's Disease — Emory University Hospital, AtlantaRobotic Apparel to Prevent Freezing of Gait in Parkinson Disease — Harvard Science and Engineering Complex, AllstonInvestigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients — Boston University, BostonCross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD — University of Florida, GainesvilleOpen-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease — Invicro (dba Perceptive), New HavenSafety and Usability of the Cionic Neural Sleeve for Parkinson's Disease — Adapt Movement, CarlsbadChanges in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs — University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building, El PasoNYSCF Scientific Discovery Biobank — New York Stem Cell Foundation Research Institute, New YorkPsilocybin Therapy for Depression in Parkinson's Disease — University of California, San Francisco, San FranciscoKetamine for Veterans With Parkinson's Disease — San Francisco VA Medical Center, San Francisco, CA, San FranciscoUniversity of Delaware Parkinson's Disease Registry — University of Delaware, NewarkCerebellar Stimulation and Cognitive Control — University of Iowa, Iowa CityLow Voltage Electrical Stimulation for Depression in Parkinson's Patients — University of South Alabama, MobileStimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD — University of Alabama at Birmingham, BirminghamIntestinal Immunity in Neurologic Disease — Yale MS Clinic, North HavenFeasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease — Richmond VA Medical Center, Richmond, VA, RichmondUser-friendliness of a Portable Driving Simulator — Abiodun Akinwuntan, Kansas CityImaging Depression in Parkinson's Disease — Yale University, New HavenLongitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging) — UAB, BirminghamThe University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy — UAB Advanced Imaging Facility, BirminghamTreating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons — Massachusetts General Hospital, BostonCircuit-Based Deep Brain Stimulation for Parkinson's Disease P1A2&3 Catalyst — University Of Minnesota, MinneapolisUnlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton — Jefferson Moss-Magee Rehabilitation - Elkins Park, Elkins ParkCPAP for the Treatment of Supine Hypertension — Autonomic Dysfunction Center/ Vanderbilt University Medical Center, NashvilleWearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease — Purdue University, West LafayetteAutomated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator — University of California San Francisco, San FranciscoSensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease — The University of Alabama at Birmingham Hospital, BirminghamModification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3) — Univeristy of Virginia School of Nursing, CharlottesvillePhysiological Brain Atlas Development — Vanderbilt Univeristy, NashvilleParkinson's Disease and Movement Disorders Clinical Database — University of Pennsylvania, PhiladelphiaElucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia — Virginia Commonwealth University, RichmondDistinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease — The Ohio State University, Columbus[18F]F-DOPA Imaging in Patients With Autonomic Failure — Vanderbilt University Medical Center, NashvillePET Imaging Evaluation of [11C]SY08 — MGH, CharlestownRetinal Imaging in Neurodegenerative Disease — Duke University Medical Center, Durham18F-mFBG Cardiac Uptake With Lewy Body Dementia — Houston Methodist Neurological Institute, HoustonTelehealth in Lewy Body Dementia — University of Florida, GainesvilleModifiable Variables in Parkinsonism (MVP) — Bastyr University, KenmoreIdentification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder — University of Minnesota, MinneapolisPET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease — National Institutes of Health Clinical Center, BethesdaAutoimmune Features of Neurodegenerative Disorders — Columbia University Medical Center, New YorkPhase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments — Domino's Farms, Ann ArborImpact of a Biophoton Therapy on Patients With Brain Disorders — Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001, ButlerUsing the EHR to Advance Genomic Medicine Across a Diverse Health System — Penn Medicine, PhiladelphiaLongitudinal Cognitive Assessment by BoCA — Andrey Vyshedskiy, MiamiCognitive Decline Following Deep Brain Stimulation — Medical University of South Carolina, CharlestonElectrophysiology-based DBS Programming for PD — Norman Fixel Institute for Neurological Diseases, GainesvilleTranscranial Direct Current Stimulation for Motor Function and Fatigue in PD — Sanford Brain and Spine Center, FargoParkinson's Foundation Surveys — Parkinson's Foundation, MiamiEvaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease — University of Colorado Anschutz, AuroraParkinson Progression Marker Initiative Online (PPMI Online) — UCSF Movement Disorders and Neuromodulation Center (MDNC), San FranciscoThe Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease — University of Florida, Norman Fixel Institute for Neurological Diseases, GainesvilleStudy to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations — Clinical Translational Research Center at CU Anschutz, AuroraHome-Based Monitoring in Parkinson's Disease — University of Iowa Hospitals and Clinics, Iowa CityVirtual tES Device Treatment for Parkinson's Disease Motor Symptoms — U LLC Headquarters, ClevelandA Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery — University of Kentucky, LexingtonSteady Together Fall Prevention Program in the Home — InMotion Wellness Center, Beachwood10,000 Step Club: Community Walking Program for People with Parkinson's Disease — Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV, Las VegasRemote Haptic Rehabilitation for Parkinson's Disease — Virginia Tech, BlacksburgCharacterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease. — University of Minnesota, MinneapolisAutologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies — University of Kentucky, LexingtonDance and Energy Expenditure Among Adults With Parkinson's — Northeastern University, BostonClinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia — Massachusetts Eye and Ear Infirmary, BostonMultiple Objective Particle Swarm Optimization Postural Instability Gait Disorder — University of Minnesota, MinneapolisTransplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) — University of California, San Diego, La JollaBOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease — Cleveland Clinic, ClevelandCorrelation of STN-DBS Induced Visuospatial Changes and Freezing of Gait — Medical University of South Carolina, CharlestonEffects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients — NYIT College of Osteopathic Medicine, Old WestburyCharacterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases — Vanderbilt University Medical Center, NashvilleEnrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. — UPMC Presbyterian Hospital, PittsburghSensing in Sleep Deep Brain Stimulation — The University of Texas Health Science Center at San Antonio - Brain Health Center, San AntonioEffects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease — Movement Disorders Laboratory, MinneapolisMulticontext Approach for Cognitive Function in Parkinson Disease — Washington University School of Medicine, St LouisNaturalistic Sleep Assessed by Wearable Devices in Parkinson Disease — University of Colorado Anschutz Medical Campus, AuroraUdall Project 1 Aim 4 — University Of Minnesota, MinneapolisDeep Brain Stimulation Surgery for Movement Disorders — National Institutes of Health Clinical Center, BethesdaDeep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease — Cleveland Clinic, ClevelandEvaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation — University of Southern California Keck School of Medicine, Los AngelesSleep-specific DBS Therapy in Parkinson's Disease — University Of Minnesota, MinneapolisSpeech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements — Michigan State University, East LansingEndurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD — UT Health San Antonio- Dept. of Physical Therapy, San AntonioCognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study — Medical University of South Carolina, CharlestonStereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor — Vanderbilt University Medical Center, NashvilleEffects of an Independent Walking Program With Walking Poles in People With Parkinson Disease — East Tennessee State University, Johnson CityAccelerated TMS for Apathy in PD — Medical University of South Carolina, CharlestonEffects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects — New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center, Old WestburySegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease — University of Texas Southwestern Medical Center, DallasUsing taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease — Wellness, Health and Research Facility at UAB, BirminghamStriatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation — University of Michigan, Ann ArborFirst-in-Human Single and Multiple Dose of HL-400 — Pharmaron CPC, Inc., BaltimoreDeep Brain Stimulation Therapy in Movement Disorders — National Institutes of Health Clinical Center, BethesdaEvaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies — Institute for Neurodegenerative Disorders and XingImaging, LLC, New HavenBalance Tele-Rehab in Parkinson's Disease — Oregon Health Science University, PortlandGlobus Pallidus Stimulation to Treat Insomnia — Mayo Clinic in Florida, JacksonvilleDaily Amino Acid Supplementation for People With Parkinson's Disease — University of Connecticut, StorrsReal-Time Levodopa Level Monitoring in Parkinson Disease — University of California San DIego, San DiegoNovel DBS Stimulation Patterns for Treatment of Parkinson's Disease — Unversity of Nebraska Medical Center, OmahaAim 3 Particle Swarm Optimization PIGD — University of Minnesota, MinneapolisUdall Project 2 Aim 2A&C — University of Minnesota, MinneapolisColonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis — Oregon Health & Science University, PortlandNeuroimaging of Parkinson's — East Imaging Building, St LouisInvestigating Inhibitory Control Networks in Parkinson's Disease — University of Alabama at Birmingham, BirminghamFacilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging — UT Southwestern Medical Center, DallasOptimizing Deep Brain Stimulation to Improve Visuomotor Function in Parkinson's Disease — Louis Stokes VA Medical Center, Cleveland, OH, Cleveland

Showing the 150 nearest — narrow your filters for fewer, closer studies.